Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kitchen, PRB; Smith, HJ; Henderson, MA; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS; Gusterson, B; Brown, RW; Gelber, RD; Collins, JP
   Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy
   ANZ journal of surgery
   
   P.R.B. Kitchen et al., "Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy", AUST NZ J S, 71(1), 2001, pp. 27-31
2. Colleoni, M; Gelber, RD; Gelber, S; Castiglione-Gertsch, M; Coates, AS; Goldhirsch, A
   How to improve timing and duration of adjuvant chemotherapy
   BREAST
   
   M. Colleoni et al., "How to improve timing and duration of adjuvant chemotherapy", BREAST, 10, 2001, pp. 101-105
3. Thurlimann, B; Price, KN; Castiglione, M; Coates, AS; Goldhirsch, A; Gelber, RD; Forbes, J; Holmberg, S; Veronesi, A; Bernhard, J; Zahrieh, D
   Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93
   BREAST
   
   B. Thurlimann et al., "Randomized controlled trial of ovarian function suppression plus tamoxifenversus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11-93", BREAST, 10, 2001, pp. 130-138
4. Bonetti, M; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Coates, AS
   Features that predict responsiveness to chemotherapy and endocrine therapies
   BREAST
   
   M. Bonetti et al., "Features that predict responsiveness to chemotherapy and endocrine therapies", BREAST, 10, 2001, pp. 147-157
5. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
   Quality of life scores predict outcome in metastatic but not in early breast cancer
   BREAST
   
   A.S. Coates et al., "Quality of life scores predict outcome in metastatic but not in early breast cancer", BREAST, 10, 2001, pp. 164-170
6. Gelber, S; Coates, AS; Goldhirsch, A; Castiglione-Gertsch, M; Marini, G; Lindtner, J; Edelmann, DZ; Gudgeon, A; Harvey, V; Gelber, RD
   Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Gelber et al., "Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer", J CL ONCOL, 19(6), 2001, pp. 1671-1675
7. Schwartz, CL; Thompson, EB; Gelber, RD; Young, ML; Chilton, D; Cohen, HJ; Sallan, SE
   Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia
   JOURNAL OF CLINICAL ONCOLOGY
   
   C.L. Schwartz et al., "Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia", J CL ONCOL, 19(4), 2001, pp. 1040-1046
8. Earle, CC; Tsai, JS; Gelber, RD; Weinstein, MC; Neumann, PJ; Weeks, JC
   Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis
   JOURNAL OF CLINICAL ONCOLOGY
   
   C.C. Earle et al., "Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis", J CL ONCOL, 19(4), 2001, pp. 1064-1070
9. Colleoni, M; Gelber, S; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, SB; Cortes-Funes, H; Simoncini, E; Murray, E; Fey, M; Goldhirsch, A
   Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   M. Colleoni et al., "Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer", J CL ONCOL, 19(21), 2001, pp. 4141-4149
10. Goldhirsch, A; Glick, JH; Gelber, RD; Coates, AS; Senn, HJ
    Meeting highlights: International consensus panel on the treatment of primary breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    A. Goldhirsch et al., "Meeting highlights: International consensus panel on the treatment of primary breast cancer", J CL ONCOL, 19(18), 2001, pp. 3817-3827
11. Gelber, S; Gelber, RD; Coates, AS; Goldhrisch, A; Castiglione-Gertsch, M
    Too early to say that pregnancy has an antitumor effect on breast cancer -In reply
    JOURNAL OF CLINICAL ONCOLOGY
    
    S. Gelber et al., "Too early to say that pregnancy has an antitumor effect on breast cancer -In reply", J CL ONCOL, 19(16), 2001, pp. 3708-3708
12. Strauss, AJ; Su, JT; Dalton, WMK; Gelber, RD; Sallan, SE; Silverman, LB
    Bony morbidity in children treated for acute lymphoblastic leukemia
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.J. Strauss et al., "Bony morbidity in children treated for acute lymphoblastic leukemia", J CL ONCOL, 19(12), 2001, pp. 3066-3072
13. Cole, BF; Gelber, RD; Gelber, S; Coates, AS; Goldhirsch, A
    Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
    LANCET
    
    B.F. Cole et al., "Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis", LANCET, 358(9278), 2001, pp. 277-286
14. Waber, DP; Shapiro, BL; Carpentieri, SC; Gelber, RD; Zou, GY; Dufresne, A; Romero, I; Tarbell, NJ; Silverman, LB; Sallan, SE
    Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia - A 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01
    CANCER
    
    D.P. Waber et al., "Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia - A 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01", CANCER, 92(1), 2001, pp. 15-22
15. Silverman, LB; Gelber, RD; Dalton, VK; Asselin, BL; Barr, RD; Clavell, LA; Hurwitz, CA; Moghrabi, A; Samson, Y; Schorin, MA; Arkin, S; Declerck, L; Cohen, HJ; Sallan, SE
    Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
    BLOOD
    
    L.B. Silverman et al., "Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01", BLOOD, 97(5), 2001, pp. 1211-1218
16. Fine, JP; Gelber, RD
    Joint regression analysis of survival and quality-adjusted survival
    BIOMETRICS
    
    J.P. Fine e R.D. Gelber, "Joint regression analysis of survival and quality-adjusted survival", BIOMETRICS, 57(2), 2001, pp. 376-382
17. Nakamura, S; Gelber, RD; Blattner, S; Sallan, SE; Chanock, SJ
    Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    
    S. Nakamura et al., "Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children", INT J PED H, 6(5), 2000, pp. 321-330
18. Castiglione-Gertsch, M; Gelber, RD; O'Neill, A; Coates, AS; Goldhirsch, A
    Systemic adjuvant treatment for premenopausal node-negative breast cancer
    EUROPEAN JOURNAL OF CANCER
    
    M. Castiglione-Gertsch et al., "Systemic adjuvant treatment for premenopausal node-negative breast cancer", EUR J CANC, 36(4), 2000, pp. 549-550
19. Silverman, LB; Declerck, L; Gelber, RD; Dalton, VK; Asselin, BL; Barr, RD; Clavell, LA; Hurwitz, CA; Moghrabi, A; Samson, Y; Schorin, MA; Lipton, JM; Cohen, HJ; Sallan, SE
    Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)
    LEUKEMIA
    
    L.B. Silverman et al., "Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)", LEUKEMIA, 14(12), 2000, pp. 2247-2256
20. Crivellari, D; Bonetti, M; Castiglione-Gertsch, M; Gelber, RD; Rudenstam, CM; Thurlimann, B; Price, KN; Coates, AS; Hurny, C; Bernhard, J; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Goldhirsch, A
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
    JOURNAL OF CLINICAL ONCOLOGY
    
    D. Crivellari et al., "Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII", J CL ONCOL, 18(7), 2000, pp. 1412-1422
21. Colleoni, M; Bonetti, M; Coates, AS; Castiglione-Gertsch, M; Gelber, RD; Price, K; Rudenstam, CM; Lindtner, J; Collins, J; Thurlimann, B; Holmberg, S; Veronesi, A; Marini, G; Goldhirsch, A
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors", J CL ONCOL, 18(3), 2000, pp. 584-590
22. Colleoni, M; O'Neill, A; Goldhirsch, A; Gelber, RD; Bonetti, M; Thurlimann, B; Price, KN; Castiglione-Gertsch, M; Coates, AS; Lindtner, J; Collins, J; Senn, HJ; Cavalli, F; Forbes, J; Gudgeon, A; Simoncini, E; Cortes-Funes, H; Veronesi, A; Fey, M; Rudenstam, CM
    Identifying breast cancer patients at high risk for bone metastases
    JOURNAL OF CLINICAL ONCOLOGY
    
    M. Colleoni et al., "Identifying breast cancer patients at high risk for bone metastases", J CL ONCOL, 18(23), 2000, pp. 3925-3935
23. Coates, AS; Hurny, C; Peterson, HF; Bernhard, J; Castiglione-Gertsch, M; Gelber, RD; Goldhirsch, A
    Quality-of-life scores predict outcome in metastatic but not early breast cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    A.S. Coates et al., "Quality-of-life scores predict outcome in metastatic but not early breast cancer", J CL ONCOL, 18(22), 2000, pp. 3768-3774
24. Bonetti, M; Gelber, RD
    A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data
    STATISTICS IN MEDICINE
    
    M. Bonetti e R.D. Gelber, "A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data", STAT MED, 19(19), 2000, pp. 2595-2609
25. Goldhirsch, A; Francis, P; Castiglione-Gertsch, M; Gelber, RD; Coates, AS
    Taxanes as adjuvant for breast cancer
    LANCET
    
    A. Goldhirsch et al., "Taxanes as adjuvant for breast cancer", LANCET, 356(9228), 2000, pp. 507-508
26. Aebi, S; Gelber, S; Castiglione-Gertsch, M; Gelber, RD; Collins, J; Thurlimann, B; Rudenstam, CM; Lindtner, J; Crivellari, D; Cortes-Funes, H; Simoncini, E; Werner, ID; Coates, AS; Goldhirsch, A
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    LANCET
    
    S. Aebi et al., "Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?", LANCET, 355(9218), 2000, pp. 1869-1874
27. Earle, CC; Venditti, LN; Neumann, PJ; Gelber, RD; Weinstein, MC; Potosky, AL; Weeks, JC
    Who gets chemotherapy for metastatic lung cancer?
    CHEST
    
    C.C. Earle et al., "Who gets chemotherapy for metastatic lung cancer?", CHEST, 117(5), 2000, pp. 1239-1246
28. Hurwitz, CA; Silverman, LB; Schorin, MA; Clavell, LA; Dalton, VK; Glick, KM; Gelber, RD; Sallan, SE
    Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia
    CANCER
    
    C.A. Hurwitz et al., "Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia", CANCER, 88(8), 2000, pp. 1964-1969
29. Asselin, BL; Kreissman, S; Coppola, DJ; Bernal, SD; Leavitt, PR; Gelber, RD; Sallan, SE; Cohen, HJ
    Prognostic significance of early response to a single dose of asparaginasein childhood acute lymphoblastic leukemia
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    B.L. Asselin et al., "Prognostic significance of early response to a single dose of asparaginasein childhood acute lymphoblastic leukemia", J PED H ONC, 21(1), 1999, pp. 6-12
30. Parsons, SK; Gelber, S; Cole, BF; Ravindranath, Y; Ogden, A; Yeager, AM; Chang, M; Shuster, J; Weinstein, HJ; Gelber, RD
    Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821
    JOURNAL OF CLINICAL ONCOLOGY
    
    S.K. Parsons et al., "Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group study 8821", J CL ONCOL, 17(7), 1999, pp. 2144-2152
31. Cote, RJ; Peterson, HF; Chaiwun, B; Gelber, RD; Goldhirsch, A; Castiglione-Gertsch, M; Gusterson, B; Neville, AM
    Role of immunohistochemical detection of lymph-node metastases in management of breast cancer
    LANCET
    
    R.J. Cote et al., "Role of immunohistochemical detection of lymph-node metastases in management of breast cancer", LANCET, 354(9182), 1999, pp. 896-900
32. Colleoni, M; Price, KN; Castiglione-Gertsch, M; Gelber, RD; Coates, AS; Goldhirsch, A
    Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil
    LANCET
    
    M. Colleoni et al., "Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil", LANCET, 354(9173), 1999, pp. 130-131
33. Gelber, RD; Shapiro, DE
    Mode of delivery and the risk of vertical transmission of HIV-1
    NEW ENGLAND JOURNAL OF MEDICINE
    
    R.D. Gelber e D.E. Shapiro, "Mode of delivery and the risk of vertical transmission of HIV-1", N ENG J MED, 341(3), 1999, pp. 206-206
34. Silverman, LB; Gelber, RD; Young, ML; Dalton, VK; Barr, RD; Sallan, SE
    Induction failure in acute lymphoblastic leukemia of childhood
    CANCER
    
    L.B. Silverman et al., "Induction failure in acute lymphoblastic leukemia of childhood", CANCER, 85(6), 1999, pp. 1395-1404
35. Bonetti, M; Cole, BF; Gelber, RD
    A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
    
    M. Bonetti et al., "A method-of-moments estimation procedure for categorical quality-of-life data with nonignorable missingness", J AM STAT A, 94(448), 1999, pp. 1025-1034
36. BILLETT AL; GELBER RD; TARBELL NJ; DALTON V; DONNELLY M; SALLAN SE
    RESULTS OF DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PROTOCOLS
    International journal of pediatric hematology/oncology
    
    A.L. Billett et al., "RESULTS OF DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PROTOCOLS", International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 115-123
37. PAGANI O; ONEILL A; CASTIGLIONE M; GELBER RD; GOLDHIRSCH A; RUDENSTAM CM; LINDTNER J; COLLINS J; CRIVELLARI D; COATES A; CAVALLI F; THURLIMANN B; SIMONCINI E; FEY M; PRICE K; SENN HJ
    PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
    European journal of cancer
    
    O. Pagani et al., "PROGNOSTIC IMPACT OF AMENORRHEA AFTER ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL BREAST-CANCER PATIENTS WITH AXILLARY NODE INVOLVEMENT - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI", European journal of cancer, 34(5), 1998, pp. 632-640
38. COLLEONI M; PRICE K; CASTIGLIONEGERTSCH M; GOLDHIRSCH A; COATES A; LINDTNER J; COLLINS J; GELBER RD; THURLIMANN B; RUDENSTAM CM
    DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER
    European journal of cancer
    
    M. Colleoni et al., "DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER", European journal of cancer, 34(11), 1998, pp. 1693-1700
39. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON CW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M
    THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE
    European journal of cancer
    
    S.E. Pinder et al., "THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE", European journal of cancer, 34, 1998, pp. 513-513
40. GELBER RD; GELBER S; BONETTI M; GOLDHIRSCH A
    QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT
    European journal of cancer
    
    R.D. Gelber et al., "QUALITY-OF-LIFE ASSESSMENT IN THE ADJUVANT SETTING - IS IT RELEVANT", European journal of cancer, 34, 1998, pp. 37-37
41. GOLDHIRSCH A; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION
    Annals of oncology
    
    A. Goldhirsch et al., "NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION", Annals of oncology, 9(9), 1998, pp. 973-976
42. GOLDHIRSCH A; COLLEONI M; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
    ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE
    Annals of oncology
    
    A. Goldhirsch et al., "ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE", Annals of oncology, 9(5), 1998, pp. 489-493
43. DALTON VMK; GELBER RD; LI F; DONNELLY MJ; TARBELL NJ; SALLAN SE
    2ND MALIGNANCIES IN PATIENTS TREATED FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    Journal of clinical oncology
    
    V.M.K. Dalton et al., "2ND MALIGNANCIES IN PATIENTS TREATED FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA", Journal of clinical oncology, 16(8), 1998, pp. 2848-2853
44. COLE BF; SOLALCELIGNY P; GELBER RD; LEPAGE E; GISSELBRECHT C; REYES F; SEBBAN C; SUGANO D; TENDLER C; GOLDHIRSCH A
    QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING
    Journal of clinical oncology
    
    B.F. Cole et al., "QUALITY-OF-LIFE-ADJUSTED SURVIVAL ANALYSIS OF INTERFERON-ALPHA-2B TREATMENT FOR ADVANCED FOLLICULAR LYMPHOMA - AN AID TO CLINICAL DECISION-MAKING", Journal of clinical oncology, 16(7), 1998, pp. 2339-2344
45. GOLDHIRSCH A; COATES AS; COLLEONI M; CASTIGLIONEGERTSCH M; GELBER RD
    ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE
    Journal of clinical oncology
    
    A. Goldhirsch et al., "ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE", Journal of clinical oncology, 16(4), 1998, pp. 1358-1362
46. COLE BF; GELBER RD; GOLDHIRSCH A
    CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY
    Journal of clinical oncology
    
    B.F. Cole et al., "CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY", Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
47. COLE BF; GELBER RD; KIRKWOOD JM
    SURVIVAL BENEFIT IN MELANOMA
    Journal of clinical oncology
    
    B.F. Cole et al., "SURVIVAL BENEFIT IN MELANOMA", Journal of clinical oncology, 16(1), 1998, pp. 388-389
48. BERNHARD J; GELBER RD; HURNY C
    WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE
    Statistics in medicine
    
    J. Bernhard et al., "WORKSHOP ON MISSING DATA IN QUALITY-OF-LIFE RESEARCH IN CANCER CLINICAL-TRIALS - PRACTICAL AND METHODOLOGICAL ISSUES - PREFACE", Statistics in medicine, 17(5-7), 1998, pp. 511-512
49. BERNHARD J; PETERSON HF; COATES AS; GUSSET H; ISLEY M; HINKLE R; GELBER RD; CASTIGLIONEGERTSCH M; HURNY C
    QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA
    Statistics in medicine
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA", Statistics in medicine, 17(5-7), 1998, pp. 587-601
50. GLASZIOU PP; COLE BF; GELBER RD; HILDEN J; SIMES RJ
    QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES
    Statistics in medicine
    
    P.P. Glasziou et al., "QUALITY-ADJUSTED SURVIVAL ANALYSIS WITH REPEATED QUALITY-OF-LIFE MEASURES", Statistics in medicine, 17(11), 1998, pp. 1215-1229
51. COATES AS; GELBER RD; GOLDHIRSCH A
    SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW
    Lancet
    
    A.S. Coates et al., "SUBSETS WITHIN THE CHEMOTHERAPY OVERVIEW", Lancet, 352(9142), 1998, pp. 1783-1784
52. ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; BENRAADT J; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; GATES GD; POWELL J; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; BERRY D; BROADWATER G; CIRRINCIONE C; MUSS H; NORTON L; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; GORDON NH; DAVIS HL; ROMESTAING P; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; PORTNOJ SM; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; COMIS RL; DAVIDSON NE; GRAY R; ROBERT N; TORMEY DC; WOOD W; CHETTY U; FORREST P; JACK W; ROSSBACH J; SYLVESTER RJ; VANDEVELDE CJH; CUNNINGHAM MP; BONNETERRE J; FUMOLEAU P; NAMER M; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DESCHRYVER A; BELFIGLIO M; MARI E; NICOLUCCI A; SCORPIGLIONE N; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; RUBAGOTTI A; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLAFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVILLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; WELVAART K; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; INGLE JN; SUMAN VJ; BUZDAR AU; SMITH T; HAKES T; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; MYLES JD; PATER JL; PRITCHARD KI; ANDERSON S; BROWN A; BRYANT J; COSTANTINO J; DIGNAM J; FISHER B; REDMOND C; WIEAND S; WOLMARK N; JACKSON IM; PALMER MK; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; UEO H; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; HARRIS A; BEIGHTON A; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JACKSON D; JAMES S; LAU E; MEAD G; NAUGHTEN A; PETO R; TOOTH A; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CI; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; GEORGE WD; GOULD A; STEWART HJ; STRONER P; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; GNANT M; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
    POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
    Lancet
    
    O. Abe et al., "POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS", Lancet, 352(9132), 1998, pp. 930-942
53. GOLDHIRSCH A; COATES AS; COLLEONI M; GELBER RD
    RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
    The New England journal of medicine
    
    A. Goldhirsch et al., "RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER", The New England journal of medicine, 338(5), 1998, pp. 330-331
54. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON GW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; GUSTERSON BA
    THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY
    Cancer
    
    S.E. Pinder et al., "THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY", Cancer, 83(8), 1998, pp. 1529-1539
55. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS
    British Journal of Cancer
    
    J. Bernhard et al., "FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS", British Journal of Cancer, 78(5), 1998, pp. 686-693
56. GOLDHIRSCH A; GLICK JH; GELBER RD; SENN HJ
    MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER
    Journal of the National Cancer Institute
    
    A. Goldhirsch et al., "MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER", Journal of the National Cancer Institute, 90(21), 1998, pp. 1601-1608
57. BERNHARD J; HURNY C; PETERSON HF; GELBER RD; CASTIGLIONEGERTSCH M; COATES AS
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER
    Quality of life research
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER", Quality of life research, 6(7-8), 1997, pp. 36-36
58. CASTIGLIONEGERTSCH M; TATTERSALL M; HACKING A; GOLDHIRSCH A; GUDGEON A; GELBER RD; LINDTNER J; COATES A; COLLINS J; ISLEY M; SENN HJ; RUDENSTAM CM
    RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY
    European journal of cancer
    
    M. Castiglionegertsch et al., "RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY", European journal of cancer, 33(14), 1997, pp. 2321-2325
59. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
    QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH
    Annals of oncology
    
    J. Bernhard et al., "QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH", Annals of oncology, 8(9), 1997, pp. 825-835
60. GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; ONEILL A; THURLIMANN B; RUDENSTAM CM; LINDTNER J; COLLINS J; FORBES J; CRIVELLARI D; COATES A; CAVALLI F; SIMONCINI E; FEY MF; PAGANI O; PRICE K; SENN HJ
    MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI
    Annals of oncology
    
    A. Goldhirsch et al., "MENSTRUAL-CYCLE AND TIMING OF BREAST SURGERY IN PREMENOPAUSAL NODE-POSITIVE BREAST-CANCER - RESULTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP (IBCSG) TRIAL-VI", Annals of oncology, 8(8), 1997, pp. 751-756
61. PESTALOZZI BC; PETERSON HF; GELBER RD; GOLDHIRSCH A; GUSTERSON BA; TRIHIA H; LINDTNER J; CORTESFUNES H; SIMMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; ALLEGRA CJ; JOHNSTON PG
    PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER
    Journal of clinical oncology
    
    B.C. Pestalozzi et al., "PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER", Journal of clinical oncology, 15(5), 1997, pp. 1923-1931
62. LIPSHULTZ SE; LIPSITZ SR; SALLAN SE; MONE SM; GELBER RD; COHEN SD
    IS ENALAPRIL BENEFICIAL IN DOXORUBICIN-TREATED LONG-TERM SURVIVORS OFCHILDHOOD-CANCER
    Circulation
    
    S.E. Lipshultz et al., "IS ENALAPRIL BENEFICIAL IN DOXORUBICIN-TREATED LONG-TERM SURVIVORS OFCHILDHOOD-CANCER", Circulation, 96(8), 1997, pp. 2438-2438
63. SILVERMAN LB; MCLEAN TW; GELBER RD; DONNELLY MJ; GILLILAND DG; TARBELL NJ; SALLAN SE
    INTENSIFIED THERAPY FOR INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM THE DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM
    Cancer
    
    L.B. Silverman et al., "INTENSIFIED THERAPY FOR INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS FROM THE DANA-FARBER-CANCER-INSTITUTE-CONSORTIUM", Cancer, 80(12), 1997, pp. 2285-2295
64. DALTON VMK; GELBER RD; DONNELLY MJ; TARBELL NJ; SALLAN SE
    2ND MALIGNANT NEOPLASMS (SMN) IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    Blood
    
    V.M.K. Dalton et al., "2ND MALIGNANT NEOPLASMS (SMN) IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)", Blood, 90(10), 1997, pp. 2491-2491
65. GELBER RD
    GEMCITABINE FOR PANCREATIC-CANCER - HOW HARD TO LOOK FOR CLINICAL BENEFIT - AN AMERICAN PERSPECTIVE
    Annals of oncology
    
    R.D. Gelber, "GEMCITABINE FOR PANCREATIC-CANCER - HOW HARD TO LOOK FOR CLINICAL BENEFIT - AN AMERICAN PERSPECTIVE", Annals of oncology, 7(4), 1996, pp. 335-337
66. MARINI G; MURRAY S; GOLDHIRSCH A; GELBER RD; CASTIGLIONEGERTSCH M; PRICE KN; TATTERSALL MHN; RUDENSTAM CM; COLLINS J; LINDTNER J; CAVALLI F; CORTESFUNES H; GUDGEON A; FORBES JF; GALLIGIONI E; COATES AS; SENN HJ
    THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER
    Annals of oncology
    
    G. Marini et al., "THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER", Annals of oncology, 7(3), 1996, pp. 245-250
67. COLE BF; GELBER RD; KIRKWOOD JM; GOLDHIRSCH A; BARYLAK E; BORDEN E
    QUALITY-OF-LIFE - ADJUSTED SURVIVAL ANALYSIS OF INTERFERON ALFA-2B ADJUVANT TREATMENT OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY
    Journal of clinical oncology
    
    B.F. Cole et al., "QUALITY-OF-LIFE - ADJUSTED SURVIVAL ANALYSIS OF INTERFERON ALFA-2B ADJUVANT TREATMENT OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY", Journal of clinical oncology, 14(10), 1996, pp. 2666-2673
68. WALLGREN A; BERNIER J; GELBER RD; GOLDHIRSCH A; RONCADIN M; JOSEPH D; CASTIGLIONEGERTSCH M
    TIMING OF RADIOTHERAPY AND CHEMOTHERAPY FOLLOWING BREAST-CONSERVING SURGERY FOR PATIENTS WITH NODE-POSITIVE BREAST-CANCER
    International journal of radiation oncology, biology, physics
    
    A. Wallgren et al., "TIMING OF RADIOTHERAPY AND CHEMOTHERAPY FOLLOWING BREAST-CONSERVING SURGERY FOR PATIENTS WITH NODE-POSITIVE BREAST-CANCER", International journal of radiation oncology, biology, physics, 35(4), 1996, pp. 649-659
69. CLARKE M; COLLINS R; DAVIES C; GODWIN J; GRAY R; PETO R; ABE O; ABE R; ENOMOTO K; KIKUCHI K; KOYAMA H; NOMURA Y; SAKAI K; SUGIMACHI K; TOMINAGA T; UCHINO J; YOSHIDA M; VANDEVELDE AO; VANDONGEN JA; VERMORKEN JB; ARVELAKIS A; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; COATES A; FORBES JF; FOCAN C; LOBELLE JP; PEEK U; OATES GD; POWELL J; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; DURAND M; MAURIAC L; BARTHOLOMEUS S; PICCART MJ; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; MASOOD MB; PARKER D; PRICE JJ; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; CIRRINCIONE C; KORZUN A; WEISS RB; WOOD WC; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; HORGAN K; HUGHES L; STEWART HJ; GORDON NH; DAVIS HL; LEHINGUE Y; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; ABELOFF MD; CARBONE PC; GLICK J; TORMEY DC; ROSSBACH J; SCANLON EF; SCHURMAN S; DESCHRYVER A; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; ERAZO A; MEDINA JY; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; FENTIMAN IS; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; FOUNTZILAS G; KLEFSTROM P; BLOMQVIST C; CUZICK J; MARGREITER R; CASTIGLIONE M; CAVALLI F; COLLINS J; FORBES J; GELBER RD; GOLDHIRSCH A; LINDTNER J; PRICE KN; RUDENSTAM CM; SENN HJ; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BOROVIK R; BRUFMAN G; HAYAT H; ROBINSON E; WIGLER N; PANNUTI F; TAKASHIMA S; TASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; HUPPERETS PSGJ; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; AHMANN D; SCHAID DJ; BUZDAR AU; SMITH T; HAKES T; NORTON L; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; BROWN A; FISHER B; REDMOND C; WOLMARK N; JACKSON IM; PALMER MK; INGLE JN; SUMAN VJ; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; NISSENMEYER R; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; NAKAMURA Y; MATHE G; MISSET JL; ABUZAHRA HT; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MYLES JD; PATER JL; PRITCHARD KI; MORIMOTO K; SAWA K; TAKATSUKA Y; GUNDERSEN S; HAUERJENSEN M; HOST A; CROSSLEY E; DURRANT K; HARRIS A; BEIGHTON A; COLLINS R; EVANS V; GREAVES E; HARWOOD C; JAMES S; LAU E; MEAD G; MULDAL A; NAUGHTON A; TOOTH A; WHEATLEY K; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPEILMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; FALKSON CJ; ABRAHAM M; KLIJN JGM; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; HOST H; BRYANT AJS; EWING GH; KRUSHENKOSLOSKI JL; FORREST APM; JACK W; MCDONALD C; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; MARTINO S; OSBORNE CK; RAVDIN PM; RUTQVIST LE; WALLGREN A; HOLM LE; YOSHIMOTO M; DEBOER G; PATERSON AHG; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLE M; SENANAYAKE F; BERGH J; HOLMBERG L; SEVELDA P; ZIELINSKY CC; JAKESZ R; GNANT M; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
    OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
    Lancet
    
    M. Clarke et al., "OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS", Lancet, 348(9036), 1996, pp. 1189-1196
70. HURNY C; BERNHARD J; COATES AS; CASTIGLIONEGERTSCH M; PETERSON HF; GELBER RD; FORBES JF; RUDENSTAM CM; SIMONCINI E; CRIVELLARI D; GOLDHIRSCH A; SENN HJ
    IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER
    Lancet
    
    C. Hurny et al., "IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER", Lancet, 347(9011), 1996, pp. 1279-1284
71. GELBER RD; COLE BF; GOLDHIRSCH A; ROSE C; FISHER B; OSBORNE CK; BOCCARDO F; GRAY R; GORDON NH; BENGTSSON NO; SEVELDA P
    ADJUVANT CHEMOTHERAPY PLUS TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE FOR POSTMENOPAUSAL BREAST-CANCER - METAANALYSIS OF QUALITY-ADJUSTED SURVIVAL
    Lancet
    
    R.D. Gelber et al., "ADJUVANT CHEMOTHERAPY PLUS TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE FOR POSTMENOPAUSAL BREAST-CANCER - METAANALYSIS OF QUALITY-ADJUSTED SURVIVAL", Lancet, 347(9008), 1996, pp. 1066-1071
72. GOLDHIRSCH A; GELBER RD
    ENDOCRINE THERAPIES OF BREAST-CANCER
    Seminars in oncology
    
    A. Goldhirsch e R.D. Gelber, "ENDOCRINE THERAPIES OF BREAST-CANCER", Seminars in oncology, 23(4), 1996, pp. 494-505
73. SPERLING RS; SHAPIRO DE; COOMBS RW; TODD JA; HERMAN SA; MCSHERRY GD; OSULLIVAN MJ; VANDYKE RB; JIMENEZ E; ROUZIOUX C; FLYNN PM; SULLIVAN JL; SPECTOR SA; DIAZ C; ROONEY J; BALSLEY J; GELBER RD; CONNOR EM
    MATERNAL VIRAL LOAD, ZIDOVUDINE TREATMENT, AND THE RISK OF TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM MOTHER-TO-INFANT
    The New England journal of medicine
    
    R.S. Sperling et al., "MATERNAL VIRAL LOAD, ZIDOVUDINE TREATMENT, AND THE RISK OF TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM MOTHER-TO-INFANT", The New England journal of medicine, 335(22), 1996, pp. 1621-1629
74. HORNY C; BERNHARD J; COATES A; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; RUDENSTAM CM; COLLINS J; LINDTNER J; GOLDHIRSCH A; SENN HJ
    RESPONSIVENESS OF A SINGLE-ITEM INDICATOR VERSUS A MULTIITEM SCALE - ASSESSMENT OF EMOTIONAL WELL-BEING IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL
    Medical care
    
    C. Horny et al., "RESPONSIVENESS OF A SINGLE-ITEM INDICATOR VERSUS A MULTIITEM SCALE - ASSESSMENT OF EMOTIONAL WELL-BEING IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL", Medical care, 34(3), 1996, pp. 234-248
75. SILVERMAN LB; MCLEAN TW; DONNELLY MJ; GILLILAND DG; GELBER RD; SALLAN SE
    IMPROVED OUTCOME FOR INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH INTENSIFICATION OF THERAPY
    Blood
    
    L.B. Silverman et al., "IMPROVED OUTCOME FOR INFANTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH INTENSIFICATION OF THERAPY", Blood, 88(10), 1996, pp. 2660-2660
76. GELBER RD; GOLDHIRSCH A; COLE BF; KROOK JE
    A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER - RESPONSE
    Journal of the National Cancer Institute
    
    R.D. Gelber et al., "A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER - RESPONSE", Journal of the National Cancer Institute, 88(22), 1996, pp. 1686-1686
77. GELBER RD; GOLDHIRSCH A; COLE BF; WIEAND HS; SCHROEDER G; KROOK JE
    A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER
    Journal of the National Cancer Institute
    
    R.D. Gelber et al., "A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER", Journal of the National Cancer Institute, 88(15), 1996, pp. 1039-1045
78. SCHWARTZ CE; COLE BF; VICKREY BG; GELBER RD
    THE Q-TWIST APPROACH TO ASSESSING HEALTH-RELATED QUALITY-OF-LIFE IN EPILEPSY
    Quality of life research
    
    C.E. Schwartz et al., "THE Q-TWIST APPROACH TO ASSESSING HEALTH-RELATED QUALITY-OF-LIFE IN EPILEPSY", Quality of life research, 4(2), 1995, pp. 135-141
79. GOLDHIRSCH A; WOOD WC; SENN HJ; GLICK JH; GELBER RD
    INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER
    European journal of cancer
    
    A. Goldhirsch et al., "INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER", European journal of cancer, 31A(11), 1995, pp. 1754-1759
80. CRIVELLARI D; PRICE KN; HAGEN M; GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; COATES AS; RUDENSTAM CM; COLLINS J; LINDTNER J; CORTESFUNES H; GUDGEON A; SIMONCINI E; BYRNE M; SCHNURCH HG; FEY M; TATTERSALL MHN; FORBES JF; CAVALLI F; SENN HJ
    ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER
    Annals of oncology
    
    D. Crivellari et al., "ROUTINE TESTS DURING FOLLOW-UP OF PATIENTS AFTER PRIMARY-TREATMENT FOR OPERABLE BREAST-CANCER", Annals of oncology, 6(8), 1995, pp. 769-776
81. COLE BF; GELBER RD; GOLDHIRSCH A
    A QUALITY-ADJUSTED SURVIVAL METAANALYSIS OF ADJUVANT CHEMOTHERAPY FORPREMENOPAUSAL BREAST-CANCER
    Statistics in medicine
    
    B.F. Cole et al., "A QUALITY-ADJUSTED SURVIVAL METAANALYSIS OF ADJUVANT CHEMOTHERAPY FORPREMENOPAUSAL BREAST-CANCER", Statistics in medicine, 14(16), 1995, pp. 1771-1784
82. HURNY C; BERNHARD J; COATES A; PETERSON HF; GELBER RD
    THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS
    JAMA, the journal of the American Medical Association
    
    C. Hurny et al., "THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS", JAMA, the journal of the American Medical Association, 273(11), 1995, pp. 843-843
83. ABE O; ABE R; ASAISHI K; ENOMOTO K; HATTORI T; IINO Y; KIKUCHI K; KOYAMA H; SAWA K; UCHINO J; YOSHIDA M; VANDEVELDE AO; VERMORKEN JB; FOROGLOU P; GIOKAS G; LISSAIOS B; HARVEY VJ; HOLDAWAY TM; KAY RG; MASON BH; FORBES JF; FOCAN C; LOBELLE JP; PEEK U; OATES GD; POWELL J; BASTERT G; RAUSCHECKER H; SAUER R; SAUERBREI W; SCHAUER A; SCHUMACHER M; GELMAN RS; HENDERSON IC; SHAPIRO CL; HANCOCK AK; JACKSON S; RAGAZ J; DELOZIER T; MACELESECH J; HAYBITTLE JL; CIRRINCIONE C; KORZUN A; WEISS RB; WOOD WC; BAUM M; HOUGHTON J; RILEY D; DENT DM; GUDGEON CA; HACKING A; HORGAN K; HUGHES L; STEWART HJ; GORDON NH; DAVIS HL; OWEN JR; MEIER P; HOWELL A; RIBEIRO GC; SWINDELL R; ALBANO J; DEOLIVEIRA CF; GERVASIO H; GORDILHO J; CARSTENSEN B; PALSHOF T; JOHANSEN H; KORZENIOWSKI S; SKOLYSZEWSKI J; ANDERSEN KW; AXELSSON CK; BLICHERTTOFT M; MOURIDSEN HT; OVERGAARD M; ROSE C; CORCORAN N; TRAMPISCH HJ; ABELOFF MD; CARBONE PC; GLICK J; GRAY R; TORMEY DC; BARTELINK H; FENTIMAN IS; PARIDAENS R; VANDRIEL OJR; SYLVESTER RJ; VANDEVELDE CJH; VANDERSCHUEREN E; VANDONGEN JA; WELVAART K; SCANLON EF; SCHURMAN S; DESCHRYVER A; YOSEF HMA; MCARDLE CS; SMITH DC; LARA PC; BOCCARDO F; IZUO M; MORISHITA Y; BENTLEY A; DORAN Z; HAYWARD JL; RUBENS RD; KAUFMANN M; JONAT W; SCHEURLEN H; VONFOURNIER D; KAUFMANN M; KLEFSTROM P; CUZICK J; MARGREITER R; CAVALLI F; COLLINS J; GELBER RD; GOLDHIRSCH A; ISLEY MR; LINDTNER J; PRICE KN; RUDENSTAM CM; BLISS JM; CHILVERS CED; COOMBES RC; MARTY M; BRUFMAN G; HAYAT H; BOROVIK R; ROBINSON E; PANNUTI F; TAKASHIMA S; YASUTOMI T; SONOO H; YAMASHITA J; OGAWA M; NOMURA Y; BONTE J; TENGRUP I; TENNVALLNITTBY L; MARTIN P; ROMAIN S; AHMANN D; SCHAID DJ; BUZDAR AU; SMITH T; HAKES T; NORTON L; WITTES R; DELAHUERTA R; SAINZ MG; BONADONNA G; DELVECCHIO M; VALAGUSSA P; VERONESI U; DUBOIS JB; BIANCO AR; LIPPMAN ME; PIERCE LJ; SIMON R; STEINBERG SM; BROWN A; FISHER B; REDMOND C; WOLMARK N; JACKSON IM; PALMER MK; INGLE JN; BENGTSSON NO; LARSSON LG; LYTHGOE JP; KISSIN M; HANNISDAL E; VARHAUG JE; BLAMEY RW; MITCHELL AK; ROBERTSON JFR; NAKAMURA Y; MATHE G; MISSET JL; CLARKE EA; MCLAUGHLIN JR; CLARK RM; LEVINE M; MORIMOTO K; GUNDERSEN S; HAUERJENSEN M; HOST H; CROSSLEY E; DURRANT K; HARRIS A; BEIGHTON A; CHADBON D; CLARKE M; COLLINS R; DAVIES C; EVANS V; GODWIN J; GREAVES E; HARWOOD C; JAMES S; MEAD G; MULDAHL A; PETO R; TOOTH A; WHEATLEY K; RAMBERT P; ASSELAIN B; SALMON RJ; VILCOQ JR; ARRIAGADA R; HILL C; LAPLANCHE A; LE MG; SPIELMANN M; COCCONI G; DIBLASIO B; CATALANO R; CREECH RH; BROCKSCHMIDT J; COOPER MR; ANDRYSEK O; BARKMANOVA J; TREURNIETDONKER AD; VANPUTTEN WLJ; EASTON D; POWLES TJ; GAZET JC; SEMIGLAZOV V; DESHPANDE N; DIMARTINO L; DOUGLAS P; LINDTNER A; NOTTER G; NISSENMEYER R; FORREST APM; JACK W; MCDONALD C; MOLLER TR; RYDEN S; CARSTENSEN J; HATSCHEK T; SODERBERG M; CARPENTER JT; ALBAIN K; CROWLEY J; GREEN S; OSBORNE CK; RUTQUIST LE; WALLGREN A; HOLM LE; CASTIGLIONE M; FLUCKIGER H; THURLIMANN B; BRENNER H; HERCBERGS A; YOSHIMOTO M; DEBOER G; PATERSON AHG; PRITCHARD KI; MEAKIN JW; PANZARELLA T; NAJA A; BAHI J; REID M; SPITTLER M; SENANAYAKE F; HOLMBERG L; SEVELDA P; ZIELINSKY CC; JAKESZ R; BUCHANAN RB; CROSS M; DUNN JA; GILLESPIE WM; KELLY K; MORRISON JM; LITTON A; CHLEBOWSKI RT; BEZWODA WR; CAFFIER H
    EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
    The New England journal of medicine
    
    O. Abe et al., "EFFECTS OF RADIOTHERAPY AND SURGERY IN EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS", The New England journal of medicine, 333(22), 1995, pp. 1444-1455
84. LIPSHULTZ SE; LIPSITZ SR; MONE SM; GOORIN AM; SALLAN SE; SANDERS SP; ORAV EJ; GELBER RD; COLAN SD
    FEMALE SEX AND HIGHER DRUG DOSE AS RISK-FACTORS FOR LATE CARDIOTOXIC EFFECTS OF DOXORUBICIN THERAPY FOR CHILDHOOD-CANCER
    The New England journal of medicine
    
    S.E. Lipshultz et al., "FEMALE SEX AND HIGHER DRUG DOSE AS RISK-FACTORS FOR LATE CARDIOTOXIC EFFECTS OF DOXORUBICIN THERAPY FOR CHILDHOOD-CANCER", The New England journal of medicine, 332(26), 1995, pp. 1738-1743
85. CONNOR E; SPERLING R; GELBER RD; BALSLEY J
    MATERNAL-INFANT TRANSMISSION OF HIV-1 - REPLY
    The New England journal of medicine
    
    E. Connor et al., "MATERNAL-INFANT TRANSMISSION OF HIV-1 - REPLY", The New England journal of medicine, 332(13), 1995, pp. 891-891
86. SPECTOR SA; GELBER RD; WARA DW
    PROPHYLACTIC IMMUNE GLOBULIN IN CHILDREN WITH HIV DISEASE - REPLY
    The New England journal of medicine
    
    S.A. Spector et al., "PROPHYLACTIC IMMUNE GLOBULIN IN CHILDREN WITH HIV DISEASE - REPLY", The New England journal of medicine, 332(11), 1995, pp. 751-752
87. GOLDHIRSCH A; GELBER RD; CASTIGLIONE M; PRICE KN; RUDENSTAM CM; LINDTNER J; COLLINS J; SENN HJ; CAVALLI F; GALLIGIONI E; FEY M; GUDGEON A; CORTESFUNES H; TATTERSALL M; MARINI G; BYRNE M; SNYDER R; FORBES JF; KAY R; HURNY C; THURLIMANN B; REED R; GUSTERSON B; TORHORST J; SAVESODERBERGH J; COATES A
    THE BEST AVAILABLE ADJUVANT TREATMENTS ARE WITHIN THE FRAMEWORK OF CLINICAL-TRIALS - THE INTERNATIONAL BREAST-CANCER STUDY-GROUP
    Israel journal of medical sciences
    
    A. Goldhirsch et al., "THE BEST AVAILABLE ADJUVANT TREATMENTS ARE WITHIN THE FRAMEWORK OF CLINICAL-TRIALS - THE INTERNATIONAL BREAST-CANCER STUDY-GROUP", Israel journal of medical sciences, 31(2-3), 1995, pp. 144-154
88. SCHWARTZ CE; COLE BF; GELBER RD
    MEASURING PATIENT-CENTERED OUTCOMES IN NEUROLOGIC DISEASE - EXTENDINGTHE Q-TWIST METHOD
    Archives of neurology
    
    C.E. Schwartz et al., "MEASURING PATIENT-CENTERED OUTCOMES IN NEUROLOGIC DISEASE - EXTENDINGTHE Q-TWIST METHOD", Archives of neurology, 52(8), 1995, pp. 754-762
89. GELBER RD; COLE BF; GELBER S; GOLDHIRSCH A
    COMPARING TREATMENTS USING QUALITY-ADJUSTED SURVIVAL - THE Q-TWIST METHOD
    The American statistician
    
    R.D. Gelber et al., "COMPARING TREATMENTS USING QUALITY-ADJUSTED SURVIVAL - THE Q-TWIST METHOD", The American statistician, 49(2), 1995, pp. 161-169
90. GELBER RD; GOLDHIRSCH A
    RE - SECTOR RESECTION WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY FOR STAGE-I BREAST-CANCER - 5-YEAR RESULTS OF A RANDOMIZED TRIAL - RESPONSE
    Journal of the National Cancer Institute
    
    R.D. Gelber e A. Goldhirsch, "RE - SECTOR RESECTION WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY FOR STAGE-I BREAST-CANCER - 5-YEAR RESULTS OF A RANDOMIZED TRIAL - RESPONSE", Journal of the National Cancer Institute, 87(9), 1995, pp. 689-689
91. GOLDHIRSCH A; WOOD WC; SENN HJ; GLICK JH; GELBER RD
    MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER
    Journal of the National Cancer Institute
    
    A. Goldhirsch et al., "MEETING HIGHLIGHTS - INTERNATIONAL CONSENSUS PANEL ON THE TREATMENT OF PRIMARY BREAST-CANCER", Journal of the National Cancer Institute, 87(19), 1995, pp. 1441-1445
92. SCHWARTZ CE; COLE BF; GELBER RD
    MEASURING PATIENT-CENTERED OUTCOMES - ADAPTING THE Q-TWIST FOR MULTIPLE-SCLEROSIS
    Quality of life research
    
    C.E. Schwartz et al., "MEASURING PATIENT-CENTERED OUTCOMES - ADAPTING THE Q-TWIST FOR MULTIPLE-SCLEROSIS", Quality of life research, 3(1), 1994, pp. 62-62
93. CASTIGLIONEGERTSCH M; JOHNSEN C; GOLDHIRSCH A; GELBER RD; RUDENSTAM CM; COLLINS J; LINDTNER J; HACKING A; CORTESFUNES H; FORBES J; SIMPSON J; TATTERSALL MHN; BRUNNER K; CAVALLI F; SENN HJ
    THE INTERNATIONAL (LUDWIG) BREAST-CANCER STUDY-GROUP TRIALS I-IV - 15YEARS FOLLOW-UP
    Annals of oncology
    
    M. Castiglionegertsch et al., "THE INTERNATIONAL (LUDWIG) BREAST-CANCER STUDY-GROUP TRIALS I-IV - 15YEARS FOLLOW-UP", Annals of oncology, 5(8), 1994, pp. 717-724
94. HURNY C; BERNHARD J; COATES A; CASTIGLIONE M; PETERSON HF; GELBER RD; RUDENSTAM CM; GOLDHIRSCH A; SENN HJ
    TIMING OF BASE-LINE QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL - ITS EFFECT ON PATIENT SELF-ESTIMATION
    Annals of oncology
    
    C. Hurny et al., "TIMING OF BASE-LINE QUALITY-OF-LIFE ASSESSMENT IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL - ITS EFFECT ON PATIENT SELF-ESTIMATION", Annals of oncology, 5(1), 1994, pp. 65-74
95. GELBER RD
    BREAST-CANCER AND ADJUVANT TREATMENT
    Biomedicine & pharmacotherapy
    
    R.D. Gelber, "BREAST-CANCER AND ADJUVANT TREATMENT", Biomedicine & pharmacotherapy, 48(8-9), 1994, pp. 409-409
96. SCHORIN MA; BLATTNER S; GELBER RD; TARBELL NJ; DONNELLY M; DALTON V; COHEN HJ; SALLAN SE
    TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF DANA-FARBER-CANCER-INSTITUTE CHILDRENS-HOSPITAL ACUTE LYMPHOBLASTIC-LEUKEMIA CONSORTIUM PROTOCOL-85-01
    Journal of clinical oncology
    
    M.A. Schorin et al., "TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF DANA-FARBER-CANCER-INSTITUTE CHILDRENS-HOSPITAL ACUTE LYMPHOBLASTIC-LEUKEMIA CONSORTIUM PROTOCOL-85-01", Journal of clinical oncology, 12(4), 1994, pp. 740-747
97. GOLDHIRSCH A; GELBER RD; PRICE KN; CASTIGLIONE M; COATES AS; RUDENSTAM CM; COLLINS J; LINDTNER J; HACKING A; MARINI G; BYRNE M; CORTESFUNES H; SCHNURCH G; BRUNNER KW; TATTERSALL MHN; FORBES J; SENN HJ
    EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE
    Lancet
    
    A. Goldhirsch et al., "EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE", Lancet, 343(8894), 1994, pp. 377-381
98. LENDERKING WR; GELBER RD; COTTON DJ
    ZIDOVUDINE AND THE QUALITY-OF-LIFE - REPLY
    The New England journal of medicine
    
    W.R. Lenderking et al., "ZIDOVUDINE AND THE QUALITY-OF-LIFE - REPLY", The New England journal of medicine, 331(5), 1994, pp. 333-333
99. SPECTOR SA; GELBER RD; MCGRATH N; WARA D; BARZILAI A; ABRAMS E; BRYSON YJ; DANKNER WM; LIVINGSTON RA; CONNOR EM; SHEARER WT; DOYLE M; HANSON CG; LAFLEN J; PELTON SI; COOPER ER; REGAN AM; TOLTZIS P; ZUCKER M; CHANCE M; YOGEV R; CHADWICK E; BAKER RC; SIEGEL R; PITT J; GERSHON AA; KANEM N; NESHEIM SR; NAHMIAS AJ; KEYSERLING HL; SAWYER MK; DOSSETT J; EYSTER ME; CUBBLE LJ; YOLKEN R; MODLIN J; VINK P; WARFORD R; HEATON S; HODES D; SACKS HS; MCSHERRY G; OLESKE J; PICARDI J; COLABELLI N; GUPTA A; BORKOWSKY W; CHANDWANI S; RIGAUD M; KAUL A; BRADY MT; HUNKLER JA; CRIM LB; BONAGURA VR; VALACER DJ; BAKSHI S; GRIECO MH; RIVERS J; MCKINLEY G; FIKRIG S; VANDYKE RB; ALCHEDIAK T; DEVEIKIS A; WONG V; CHURCH J; DORENBAUM A; PETRU A; TREBITHICK D; RICH K; CHEESEMAN S; SULLIVAN JL; LUZURIAGA K; JONES CR; GOODROAD BK; BALFOUR HH; DIAZ C; LUGO L; FLORES L; RIVERA C; BURCHETT SK; MOHAN K; FOSTER I; COREY L; STORCH G; BREUKLANDER L; ROYAL M
    CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OFSERIOUS BACTERIAL-INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    The New England journal of medicine
    
    S.A. Spector et al., "CONTROLLED TRIAL OF INTRAVENOUS IMMUNE GLOBULIN FOR THE PREVENTION OFSERIOUS BACTERIAL-INFECTIONS IN CHILDREN RECEIVING ZIDOVUDINE FOR ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION", The New England journal of medicine, 331(18), 1994, pp. 1181-1187
100. GOLDHIRSCH A; GELBER RD
     ADJUVANT THERAPY FOR BREAST-CANCER
     The New England journal of medicine
     
     A. Goldhirsch e R.D. Gelber, "ADJUVANT THERAPY FOR BREAST-CANCER", The New England journal of medicine, 331(11), 1994, pp. 745-746